FDAnews
www.fdanews.com/articles/185798-endomags-magseed-marker-cleared-for-long-term-and-soft-tissue-implantation

Endomag’s Magseed Marker Cleared for Long-Term and Soft Tissue Implantation

February 27, 2018

Endomag received 510(k) marketing clearance to extend the indication of its Magseed magnetic marker to include both the marking of soft tissue and long-term implantation. The marker is used to locate lesion for breast cancer.

The device is a wire-free localization device that can be implanted into any soft tissue with no restrictions on the length of time the marker can remain in the body. It is compatible for imaging under ultrasound, X-ray and MRI.

The system is designed to guide the accurate removal of cancer, and to maximize the amount of healthy tissue retained.

View today's stories